Devyser: Michael Uhlin

Devyser Diagnostics has appointed Michael Uhlin to its management team, effective Feb. 1. He has been the company's CSO since fall 2023 and, with his additional appointment to the management team, he will be responsible for development and innovation in the areas of bioinformatics, clinical affairs, and the firm's CLIA-certified Devyser Genomic Laboratories. Uhlin also holds a professorship at Karolinska Institutet.